Wednesday, 23 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14475
Articles
Company
Drug
J&J’s Cetrelimab and TAR-200 Gain Tacit Approvals for Bladder Cancer Trials
November 16, 2024
Company
Medical Device
Nanjing Geneseeq’s NSCLC TMB Detection Kit Approved by NMPA
November 16, 2024
Company
Drug
RemeGen Secures NMPA Approval for Phase II Study of Disitamab Vedotin in Breast Cancer
November 16, 2024
Company
Deals
Genetron Holdings Enters Privatization Agreement with Consortium
November 16, 2024
Company
Drug
Ascentage Pharma Initiates Phase III Study for APG-2575 and Calquence in CLL/SLL
November 16, 2024
Company
Drug
Betta Pharmaceuticals Secures NMPA Approval for Befotertinib in NSCLC Treatment
November 16, 2024
Company
Drug
KPC Pharmaceuticals Secures WHO Prequalification for Dihydroartemisinin/Piperaquine
November 16, 2024
Company
Novartis Halts Phase II Clinical Study for MIJ821 in Major Depressive Disorder
November 17, 2024
Company
Drug
MSD’s Keytruda Achieves Primary Endpoint in Late-Stage NSCLC Trial
December 10, 2024
Company
Bayer AG Plans Continued Investment in China Amidst Global Challenges
November 16, 2024
Company
Drug
Novo Nordisk Halts Phase III Ozempic Study on Renal Impairment in Diabetes Patients
November 17, 2024
Company
Deals
BMS Expands CAR-T Collaboration with Cellares on Automation Tech
November 16, 2024
1
2
…
865
866
867
868
869
…
1,206
1,207
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?